SEA Vision logo

SEA Vision

Industrial vision inspection, serialization, and track & trace systems for pharmaceutical manufacturing and quality control.

Pavia, IT
Founded in 1995
201-500 employees
Visit website
AI-generated from publicly available materials.Is this your company? Claim your profile

Overview

SEA Vision is a supplier of industrial vision inspection systems for the pharmaceutical industry, operating since 1995. The company develops software and hardware solutions spanning product quality control, track and trace, digitalization, and process automation, serving pharmaceutical manufacturers that require highly complex inspection and serialization capabilities.

To date, SEA Vision has installed over 2,500 complete serialization lines and more than 10,500 vision systems worldwide. The company employs a team of more than 420 people, with approximately 260 based at its Italian headquarters. The workforce has an average age of 31 and is composed largely of graduates from various scientific disciplines.

Core Solution Areas

  • Vision Inspection Systems: Industrial vision systems designed for quality control of pharmaceutical products, covering detection of defects and verification of product integrity on production lines.
  • Track and Trace / Serialization: End-to-end serialization line solutions enabling pharmaceutical manufacturers to comply with traceability requirements; over 2,500 complete serialization lines have been installed globally.
  • Digitalization and Process Automation: Software solutions aimed at digitalizing manufacturing workflows and automating production processes within pharmaceutical environments.

Company Profile and Scale

  • Founded in 1995, giving the company nearly three decades of experience in pharmaceutical vision inspection.
  • Headquarters located in Italy, with a global installation footprint exceeding 10,500 vision systems across worldwide customer sites.
  • A team of more than 420 specialists, the majority holding degrees in scientific fields, with a focus on research and development to address complex technological projects.
  • Ongoing investment in R&D underpins the company's ability to deliver solutions for highly complex and innovative pharmaceutical manufacturing challenges.